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R108mice homozygous for the murine
NOD2 mutation corresponding to the
human Crohn’s disease-associated
L1007insC mutation displayed a
striking xenophagy defect in
response to S. flexneri infection [5].
Taken together, the results by
Travassos et al. [5] establish a
mechanistic link between modulators
of innate immunity (i.e., NODs) and
the cellular machinery for autophagy
(and ATG16L1 in particular), which
cooperate in the control of bacterial
invasion. Thus, the NOD2–ATG16L1
axis appears for the first time as a
unique pathway, the deregulation of
which plays a central role in the etiology
of Crohn’s disease, with obvious
therapeutic implications. Future
investigations will have to elucidate
whether the products of other loci
that have been associated with
Crohn’s disease also interact with the
molecular machinery for xenophagy.
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RNA WorldMicroRNAs are believed to control many physiological processes in animals.
Now, two studies show that some of their presumptive functions are actually
fulfilled by another class of RNAs — siRNAs.Herve´ Seitz
Three classes of small regulatory
RNAs are known in animals:
microRNAs (miRNAs), small interfering
RNAs (siRNAs) and Piwi-interacting
RNAs (piRNAs). The first two classes
share common features: they are
loaded on the same effector proteins
(the Ago subfamily of the ‘Argonaute’
protein family) and they are generated
by the cleavage of double-stranded
RNA by nucleases of the RNase III
family. But miRNAs and siRNAs differ in
their biogenesis (Figure 1): while bothclasses are processed by a nuclease
called ‘Dicer’, the biogenesis of most
miRNAs also involves an enzyme called
‘Drosha’ (and its partner protein,
Dgcr8).
miRNAs were discovered earlier
than siRNAs (in mammals, endogenous
siRNAs were uncovered two years ago
[1–3], seven years later than miRNAs
[4]). Therefore, microRNAs have been
more extensively studied: before their
siRNA cousins were even discovered,
miRNAs had been implicated in a broad
range of biological processes, notably
in the control of development (reviewedin [5]). Mammalian siRNAs have been
shown to repress transposable
elements and a few non-transposable
genes (far less than miRNA-regulated
genes) [1,2].
In this light, the strong phenotypic
defects of Dicer-defective mice [6]
were usually interpreted as a
consequence of their lack of miRNAs.
The recent discovery of endogenous
siRNAs could challenge this belief: as
Dicer participates in the biogenesis of
both miRNAs and siRNAs (Figure 1),
these defects could actually be due to
a lack of siRNAs. Two papers in this
issue of Current Biology indeed show
that the observed defects in mouse
oocyte development must be due to
siRNAs [7,8].
In order to sort out the contribution of
miRNAs and siRNAs to the spectacular
phenotypes of Dicer-deficient oocytes,
Suh and collaborators [7] prepared a
conditional knock-out of Dgcr8. While
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Figure 1. Biogenesis of siRNAs and miRNAs.
In flies and vertebrates, siRNAs derive from long double-stranded RNAs (either bimolecular
duplexes, resulting from the annealing of a sense and an antisense RNA, or long monomolec-
ular hairpins), and they are cleaved by Dicer (in association with a variable partner protein).
miRNAs derive from monomolecular double-stranded RNA, most often cleaved by two protein
heterodimers (the nuclear Drosha enzyme, assisted by its partner Dgcr8, liberates a hairpin-
folded RNA from a longer, primary transcript; that hairpin is then exported to the cytoplasm,
where it is cleaved by the Dicer enzyme, also associated with a partner protein).
Dispatch
R109the conditional knock-out of Dicer
leads to a meiotic arrest during the first
meiotic division [9,10], Dgcr8-deficient
oocytes seem to develop normally:
they complete meiosis and can be
successfully fertilized and give healthy
pups. Thus those severe defects
observed in the absence of Dicer
cannot be attributed to the lack of
miRNAs. The authors noted, however,
that fertilization of Dgcr8-deficient
oocytes by wild-type sperm tend to
produce fewer offspring: even though
they can be successfully fertilized,
Dgcr8-deficient oocytes do not appear
to be as functional as wild-type
oocytes. This observation probably
means that miRNA-deficient oocytes
display subtle, un-noticed
abnormalities that decrease their
ability to make a healthy embryo.
Not only can oocytes fully develop
in the absence of Dgcr8, but the
developing embryo itself can manage
without miRNAs for a surprisingly long
time. Preimplantation development of
homozygous Dgcr8 mutant embryos
is apparently normal and embryos
reach as far as the blatocyst stage.
Importantly, the absence of a
phenotype is not due to maternal
deposition of Dgcr8 protein or mature
miRNAs.
The unexpected tolerance of oocytes
to the lack of Dgcr8 (hence, of miRNAs)
is explained by the findings described
in the accompanying paper by Ma and
collaborators [8]. miRNAs usually leave
a ‘signature’ on transcriptomes: most
RNAs are destabilized by microRNAs
that target them. Ma et al. [8] noticed
that Dicer-deficient oocytes do not
show any up-regulation of presumptive
targets of the oocyte’s miRNAs. In fact,
very few mRNAs were up-regulated,
which was already a surprise, given
the repertoire of miRNAs expressed
in oocytes. Those observations
suggested that miRNAs may be
inactive, or at least inefficient, in mouse
oocytes. Artificial targets for two
abundant oocyte miRNAs are indeed
poorly repressed when injected
in fully grown oocytes.
The next question is: how are
miRNAs inactivated in oocytes? Ma
et al. [8] show two intriguing results that
could help understand what is going
on. First, an artificial siRNA designed
against the 30 UTR of an endogenous
gene is very inefficient in pre- and
post-maturation oocytes, as if 30 UTRs
were inaccessible to small RNA guided
repression. Second, P-bodies(cytoplasmic foci that concentrate
miRNA-targeted mRNAs) disappear
during oocyte growth. The loss of
P-bodies is probably not the cause
for the inactivity of miRNAs
(localization to P-bodies appears to
be a mere consequence of mRNA
targeting and is dispensable for target
repression [11,12]); so the concomitant
disappearance of P-bodies and of
target repression are most probably
two consequences of a common
cause.
Suh et al.’s [7] experiments on
Dgcr8-deficient oocytes show that the
absence of miRNAs is not responsible
for the meiotic arrest in Dicer mutant
oocytes: what other Dicer-dependent
molecules could be involved? Other
obvious candidates include siRNAs,
but also atypical miRNAs, whose
biogenesis does not require Dgcr8:
mirtrons and endogenous shRNAs
(Figure 1). These atypical miRNAs
are probably not guilty: up-regulated
mRNAs in Dicer mutant oocytes
are not enriched for predicted
targets for the oocyte mirtrons
and shRNAs, in contrast to
siRNAs, which match many of these
mRNAs.
So these two papers draw a new
picture of gene regulation in mouse
oocytes: miRNAs are inactive, despite
their abundance. Another class of small
RNAs — siRNAs — probably controls
the phenotypic defects observed
in Dicer mutant oocytes. As is often
the case, these results raise a series
of new questions.The mode of action of endogenous
siRNAs is not clear: obviously, they can
guide RNA degradation by RNAi
(provided that they do not target 30
UTRs, which seem to be refractory
to siRNAs in oocytes according to
Ma et al. [8]). But they may also have
a distinct function: meiotic arrest in
Dicer mutant oocytes is accompanied
by a disorganization of the meiotic
spindle [9,10]. These defects are not
observed in Dgcr8 mutant oocytes,
indicating that they are due to siRNAs.
A recent report shows that an original
class of small RNAs is necessary
for proper chromosome segregation
during mitosis and meiosis in
Cænorhabditis elegans, without
triggering any destabilization of the
complementary RNAs [13]. Do
siRNAs play a similar role in murine
oocyte meiosis? Or, more generally,
how conserved is the role of siRNAs
in early development? It has
been known for some time that
the deletion of Dicer leads to
more severe defects in mouse
than in zebrafish (discussed in [14]),
suggesting that siRNAs are
dispensable for the early
development of zebrafish.
Another question deserves
clarification: do mammalian siRNAs
play regulatory roles in other tissues?
There may be a simple way to address
that question: long double-stranded
RNAs usually trigger a non-specific,
global translational repression known
as ‘interferon response’ (which is an
efficient antiviral defense in mammals).
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R110As siRNAs derive from such long
double-stranded RNAs, one could
expect siRNA precursors to
constitutively activate the interferon
response. except that the whole
pathway seems to be inactive in mouse
oocytes [15]. Identifying the mouse
tissues devoid of an interferon
response could prove helpful in the
search for endogenous siRNA function.
It can be expected, at least, that one
particular feature of siRNAs will not
make that task easy: endogenous
siRNAs are expressed at very low
levels — much lower than typical
miRNAs. This may be linked to
the activity of siRNAs: as guides
for the endonucleolytic cleavage of
their targets, they act catalytically,
whereas most animal miRNAs
act stoichiometrically (the target
needs to be bound by the miRNA to
be repressed, until it is degraded).
These observations suggest an
impressive, almost scary, possibility.
After the miRNA era (where so many
functions have been ascribed to
miRNAs, in so many physiological
processes), we may be entering the
‘siRNA era’. How many biological
pathways will involve siRNAs? As
siRNAs can act catalytically, minute
amounts of these novel regulators
could have tremendous effects;undetected small RNAs may lie behind
unexplained phenomena. Clearly, the
exploration of small regulatory RNAs is
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E-mail: seitz@ibcg.biotoul.frDOI: 10.1016/j.cub.2009.12.027Short RNAs: How Big Is This Iceberg?Recent studies have reported the identification of piwi-associated RNAs
(piRNAs) in Drosophila somatic cells. Interestingly, these piRNAs derive from
the 30 untranslated regions of a subset of transcribed protein-coding genes
and, experimentation suggests, might control the expression of other
protein-coding transcripts. Studies of additional organisms support the new
pathway’s presence across animals.Isidore Rigoutsos
The RNA revolution is upon us. The
last decade and a half has witnessed
a flurry of research activity revolving
around RNA, a molecule that for many
years was thought to play only ancillary
roles in the workings of a cell. Aided by
technological and scientific advances,
the repertoire of non-coding RNAs, i.e.
RNAs that do not code for proteins, has
been expanding steadily [1].
A particular class of short RNAs,
microRNAs, has so far commanded the
lion’s share of researchers’ attention.Approximately 22 nucleotides long,
microRNAs have been shown to
post-transcriptionally regulate their
targets in a sequence-dependent
manner [2]. Originally believed to
act through the 30 untranslated region
(30UTR) of the targeted mRNAs,
microRNAs were recently shown to
target the mRNA’s amino-acid coding
sequence (CDS) as well [3,4]. Recently,
piwi-associated RNAs (piRNAs),
another intriguing class of short RNAs
with lengths between 23 and 30
nucleotides, burst onto the stage [5–8].
To date, piRNAs have been reportedin Drosophila, human, mouse, rat,
Xenopus, zebrafish and the worm,
and their known numbers are in the
hundreds of thousands.
Drosophila piRNAs deriving from
heterochromatic loci that are rich in
nested, truncated, or damaged
repeat elements, termed piRNA
‘clusters’, have been among the
better studied. Such piRNAs
participate in the ‘ping-pong’ cycle,
an auto-amplification loop that is
conserved in many metazoans and
constitutes an adaptive immune
response that maintains genomic
integrity by suppressing the expression
of transposons and other repetitive
sequences [9,10].
In addition to piRNAs generated via
the ping-pong cycle, other piRNAs that
do not depend on auto-amplification
have also been reported. The specifics
of their generation had remained
elusive for a while, but recent studies
by the laboratories of Mikiko and
